Recent Finacing
Recent Raise
Fortis Therapeutics is an immuno-oncology company developing FOR46, a fully human ADC targeting a tumor‑specific conformational epitope of CD46, currently in clinical trials for multiple myeloma and mCRPC.
Focus Areas
Recent Investors
Total Raised
Funding rounds
Investors
